Phase I/II adaptive design for drug combination oncology trials (Q6929793)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 8093725
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Phase I/II adaptive design for drug combination oncology trials |
scientific article; zbMATH DE number 8093725 |
Statements
Phase I/II adaptive design for drug combination oncology trials (English)
0 references
16 September 2025
0 references
dose finding
0 references
continual reassessment method
0 references
phase II
0 references
drug combination
0 references
adaptive randomization
0 references
0 references
0 references
